Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Advanced Disease
20%
Androgen Deprivation
20%
Androgen Deprivation Therapy
40%
Androgens
20%
Anticancer Immune Response
20%
Antigen-specific
40%
Antigen-specific CD8+ T Cells
100%
Antitumor
20%
Bona Fide
40%
Cancer Causes
20%
Cancer Mortality
20%
Cancer Neoantigen
100%
Castration-sensitive
20%
CD8 T Cells
80%
Cell Tolerance
60%
Clinical Work
20%
Disease States
20%
Egg Ovalbumin
20%
Her2neu
40%
Immunosuppressive Microenvironment
20%
Influenza Hemagglutinin
20%
Lethal mutations
20%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
20%
Murine Cell Line
20%
Prostate Cancer
100%
Prostate Tumor
40%
Recurrent Disease
20%
Recurrent Prostate Cancer
20%
T Cell Infiltration
20%
T Cell Response
20%
T-cell Tolerance
100%
TLR Agonists
20%
Tumor
20%
Tumor Antigen
40%
Tumor Cancer
20%
Xenogeneic Antigen
20%
Medicine and Dentistry
Androgen
33%
Androgen Deprivation Therapy
33%
Antigen
16%
Antigen Specificity
100%
Castration Resistant Prostate Cancer
16%
Cell Line
16%
Cellular Infiltration
16%
Cytotoxic T-Cell
100%
Diseases
16%
Hemagglutinin
16%
Immune Response
16%
Immunosuppressive Drug
16%
Immunotherapy
16%
Influenza
16%
Malignant Neoplasm
33%
Neoplasm
16%
Ovalbumin
16%
Prostate Cancer
100%
Prostate Tumor
33%
Recurrent Disease
16%
T Cell
16%
T-Cell Response
16%
T-Cell Tolerance
100%
Tumor
16%
Tumor Antigen
33%
Tumor Microenvironment
16%
Immunology and Microbiology
Agonist
33%
Antigen
33%
Antigen Specificity
100%
Cell Line
33%
Cytotoxic T-Cell
100%
Hemagglutinin (Influenza)
33%
Immune Response
33%
Immunosuppressive Drug
33%
Immunotherapy
33%
Neoantigen
100%
Prostate
66%
T Cell
66%
T-Cell Tolerance
100%
Tumor Antigen
66%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
66%
Antigen
100%
Castration Resistant Prostate Cancer
16%
CD8 Antigen
100%
Diseases
16%
Hemagglutinin
16%
Immunosuppressive Agent
16%
Immunotherapy
16%
Influenza
16%
Malignant Neoplasm
33%
Neoplasm
16%
Ovalbumin
16%
Prostate Cancer
100%
Prostate Tumor
33%
Recurrent Disease
16%
Tumor Antigen
33%
Tumor Microenvironment
16%
Biochemistry, Genetics and Molecular Biology
Agonist
33%
Antigen Specificity
100%
CD8
100%
Hemagglutinin (Influenza)
33%
Immune Response
33%
Myc
33%
Ovalbumin
33%
T Cell
100%
Tumor Antigen
66%